The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass-Reference-Cited by-同舟云学术

The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass

Published:2009 Issue:5 Volume:23 Page:331-335
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J. Clin. Lab. Anal.

Author:

Montagnana Martina,Lippi Giuseppe,Ruzzenente Orazio,Bresciani Valentina,Danese Elisa,Scevarolli Silvia,Salvagno Gian Luca,Giudici Silvia,Franchi Massimo,Guidi Gian Cesare

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Reference26 articles.

1. Ovarian cancer;Colombo;Crit Rev Oncol Hematol,2006

2. A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer;Pal;Cancer,2008

3. Carcinoma of the ovary;Heitz;Int J Gynecol Obstet,2006

4. Importance of early diagnosis in managing ovarian cancer;Dunleavey;Nurs Times,2006

5. Minimizing delays in ovarian cancer diagnosis: An expansion of Andersen's model of “total patient delay”;Evans;Fam Pract,2007

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A disposable and ultrasensitive immunosensor for the detection of HE4 in human serum samples;Chemical Papers;2024-02-27

2. Relevance of glyco-biomakers and glycan profiles in cancer stem cells;Glycobiology;2023-03-02

3. Revised Cut-Off Value of Human Epididymis Protein 4 Enhances Its Use as an Ovarian Tumor Marker;Gynecologic and Obstetric Investigation;2023

4. Evaluation of HE4 as a prognostic biomarker in uterine cervical cancer,;Cancer Treatment and Research Communications;2023

5. Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients;European Journal of Translational Myology;2022-08-01